about
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialA phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinomaInitial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease.MRI of Crohn's disease: from imaging to pathology.Imaging of HCC.Dual-energy CT: oncologic applications.Systemic therapy for hepatocellular carcinoma: the issue of treatment stage migration and registration of progression using the BCLC-refined RECIST.Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever.Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design.Second-generation dual-energy computed tomography of the abdomen: radiation dose comparison with 64- and 128-row single-energy acquisition.Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis.Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib.Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?Virtual unenhanced images of the abdomen with second-generation dual-source dual-energy computed tomography: image quality and liver lesion detection.[Imaging techniques in hepatocellular carcinoma: diagnosis, extension and evaluation of therapeutic response].Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial.Non-invasive diagnosis of hepatocellular carcinoma ⩽2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRIIntrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasoundTreatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patientsCalcifications in the portal venous system: comparison of plain films, sonography, and CTChanges in portal vein flow after adult living-donor liver transplantation: Does it influence postoperative liver function?Comparison of Endoscopic Ultrasonography and Magnetic Resonance Cholangiopancreatography in the Diagnosis of Pancreatobiliary Diseases: A Prospective StudyIntestinal tuberculosis in AIDSLipomatosis of the pancreas: an unusual cause of massive steatorrhea[Growing teratoma syndrome in metastatic germinal non-seminomatous testicular tumors]Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphomaIs there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?[Usefulness of ultrasonography and computerized tomography in predicting resectability of pancreatic carcinoma][Lower esophageal sphincter pressure in patients with achalasia. Is high blood pressure frequent in these patients?]Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer[Magnetic resonance enterography in Crohn's disease: a new diagnostic tool?][Recommendations of the Spanish Biliopancreatic Club for the Treatment of Acute Pancreatitis. Consensus development conference][Imaging diagnosis of hepatocellular carcinoma. Addendum to hepatocellular carcinoma: diagnosis, staging and treatment strategies]
P50
Q29617955-C95A27AB-DE85-4BD5-B0B5-13D99DB22452Q33579629-C17D5438-141B-43DA-AF4B-B3F62B5B711EQ34552875-8213ACC7-43D3-43B0-8AB4-65D9C0D74C3FQ34635723-6E645A29-D71C-4F2D-A9D5-214092B6DB0AQ37485563-E660A90F-7665-4BE2-987D-F69F051BD11FQ37924164-AB084189-523F-4E5A-886C-EF471C8FBB77Q37930465-1FFEDFF0-BB14-4498-80B3-E4226669F156Q38055446-0C2F4943-6618-4AEF-BD07-FBC2162CDF79Q38264959-7E40D3F0-A071-41B5-AD7E-93B8F1EA6179Q40686971-EE711828-0D95-43EF-B32D-24D500EA317FQ42457047-D0D5472E-22CF-4DDA-9380-21CF4A5D6DCDQ43601180-98CA475B-6C7D-420F-A472-BCC46615F72CQ43950860-DC96F3C2-263B-4C0E-8910-1A875BA3DE0FQ46798691-7D785D32-5B95-4B2B-8C8E-4FBBB0DE4DDBQ48003715-C949A049-2930-4559-BDB6-2EDC4B82A4F6Q50461372-A767AE98-C215-45BB-B492-E5A15265C63FQ50474760-0DAA0C56-8E5F-48F7-A8C1-FB43AA3FC03AQ51082254-18C8C34C-A625-4265-BD98-B9DAA4AEAE5EQ51198337-B8110686-BD2B-471C-BBA2-6B9871C670E2Q53107824-4C679C88-A96D-43AF-B03C-BBDAADBBBB24Q53296716-B191F7EE-4C7B-43B8-8ED0-5E4A78FF437EQ53533543-61D2326C-42DE-4D84-830C-9AA15CB05114Q58021245-7DE097F7-64B6-4F85-8E96-E1CDCB5C66CEQ58021493-3B573358-EF2D-41F1-863F-327575716D22Q58022236-DE190D46-593A-4D00-977D-35C932EF0FCEQ58022276-0543533B-EE3B-4BD2-A4A3-3FADA63C2373Q58230782-6A92FDBD-73B2-40D3-A250-727AB4A500E5Q61058018-EA1B1608-4663-46DE-AC02-2CF5984C13C3Q61314724-D6DF61E9-BBFF-436D-9204-12F54DC67218Q67961437-4BF972E4-19BC-48B7-BD30-399AEF06F0FCQ68601550-D26AE682-49CF-407D-9A57-78D1C038BB1AQ72567608-F9E62DA3-C2D9-44A7-B07A-CD1427C9052EQ73439167-F43B2A4E-B726-4AD0-9890-683568B964E8Q73678702-8D775ACD-3266-440D-96A1-78A0BDCD23E9Q77767640-0ECE6719-8285-4D6D-BA0D-8C7FF2AEA80EQ80047624-485E3CDB-97B9-4549-B6DC-6E8D2F903CBCQ80242335-FE1DC9CC-5A56-45A5-BD8E-B78B1136123BQ81231560-700D1766-4579-493F-8178-A99008D69127Q81500791-A3517DEF-8F82-41C2-AA58-0051E8931824Q83749272-92BF8CAC-91C0-4E74-A06C-6DACC3192BC7
P50
description
researcher ORCID: 0000-0002-9606-6957
@en
wetenschapper
@nl
name
Carmen Ayuso
@ast
Carmen Ayuso
@en
Carmen Ayuso
@es
Carmen Ayuso
@nl
type
label
Carmen Ayuso
@ast
Carmen Ayuso
@en
Carmen Ayuso
@es
Carmen Ayuso
@nl
prefLabel
Carmen Ayuso
@ast
Carmen Ayuso
@en
Carmen Ayuso
@es
Carmen Ayuso
@nl
P214
P950
P106
P1153
7007114895
P1580
P214
P31
P496
0000-0002-9606-6957
P7859
viaf-87136458